10.99
+10.99
(-2.66%)
At close: January 24 at 4:00:00 PM EST
10.24
-0.75
(-6.82%)
Pre-Market: 7:16:56 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BASTA JAMES EDMUND General Counsel | Sale | Jan 3, 2025 | 74,497 |
| CLARK ELIANA Chief Technology Officer | Sale | Jan 3, 2025 | 64,048 |
| DUBE MICHAEL P Officer | Sale | Jan 3, 2025 | 45,640 |
| DULAC EDWARD J III Chief Financial Officer | Stock Award(Grant) | Jul 22, 2024 | 66,324 |
| GOFF BRIAN M Director | Stock Award(Grant) | Jun 13, 2024 | 15,409 |
| HICKS DEREK Officer | Sale | Jan 3, 2025 | 59,878 |
| LEBWOHL DAVID Officer | Sale | Jan 3, 2025 | 87,666 |
| LEONARD JOHN M Chief Executive Officer | Sale | Jan 3, 2025 | 999,530 |
| SEPP-LORENZINO LAURA Officer | Sale | Jan 3, 2025 | 77,388 |
| VERWIEL FRANK Director | Sale | Jun 17, 2024 | 17,948 |
Related Tickers
EDIT Editas Medicine, Inc.
1.3800
-2.13%
BEAM Beam Therapeutics Inc.
25.98
-1.18%
CRSP CRISPR Therapeutics AG
43.42
-1.83%
VERV Verve Therapeutics, Inc.
7.91
-1.00%
DNA Ginkgo Bioworks Holdings, Inc.
12.82
-2.73%
CRBU Caribou Biosciences, Inc.
1.5100
-0.66%
PRME Prime Medicine, Inc.
3.1500
-3.37%
IOVA Iovance Biotherapeutics, Inc.
6.25
+0.97%
RXRX Recursion Pharmaceuticals, Inc.
7.33
-2.66%
ABSI Absci Corporation
4.0000
-4.08%